Ledipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API Ledipasvir

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

In-stock Capacity
The supplier has In-stock capacity
Fast Delivery
The supplier can deliver the goods within 15 days
OEM Services
The supplier provides OEM services for popular brands
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (13)
  • Ledipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API Ledipasvir
  • Ledipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API Ledipasvir
  • Ledipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API Ledipasvir
  • Ledipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API Ledipasvir
  • Ledipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API Ledipasvir
  • Ledipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API Ledipasvir
Find Similar Products

Basic Info.

Certification
GMP, ISO 9001, USP
Suitable for
Adult
State
Powder
Purity
>99%
Sample
Available
OEM
Available
MOQ
1kg
CAS
1256388-51-8
Keyword
Ledipasvir
Keyword 1
Ledipasvir Powder
Transport Package
1kg Foil Bag /25kg Drum
Specification
99%
Trademark
/
Origin
China
Production Capacity
20000

Product Description

Ledipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API Ledipasvir
Description

Ledipasvir (formerly GS-5885) is a drug for the treatment of hepatitis C, it is an inhibitor of the hepatitis C virus NS5A protein. The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.

Product name Ledipasvir
Appearance white Powder
Specification 99%
Shelf life 2 years when properly stored

Function and Application

Ledipasvir is an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex,  ledipasvir is indicated for the treatment of HCV genotypes 1, 4, 5, and 6. Its use has also proven successful in the treatment of HCV in patients co-infected with HIV.

Ledipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API LedipasvirLedipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API LedipasvirLedipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API LedipasvirLedipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API LedipasvirLedipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API LedipasvirLedipasvir Powder CAS 1256388-51-8 Anti HCV Ledipasvir API Ledipasvir

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier